NQ-DCP Fluorescent Probe for hNQO1 Cancer Imaging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current fluorescent probes for detecting human NAD(P)H quinone oxidoreductase-1 (hNQO1) in cancer cells face challenges such as weak signal-to-noise ratios, limited cell permeability, insufficient Stokes shift, and restricted in vitro use, hindering effective cancer diagnosis and management.
Innovation Solution
Development of a novel fluorescent probe, NQ-DCP, conjugating quinone propionic acid with dicyanoisophorone, which undergoes activation by hNQO1 to release a highly fluorescent dicyanoisophorone, offering a large Stokes shift, high sensitivity, selectivity, low cytotoxicity, and cell permeability for both in vitro and in vivo applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional fluorescent probes are used for hNQO1 detection, then the probe structure is simple, but the signal-to-noise ratio is weak
Solution Approach 1:
The probe is divided into two functional segments: a fluorophore unit (dicyanoisophorone) that generates the fluorescent signal and a quinone propionic acid unit that serves as the hNQO1 substrate. This segmentation allows each component to be optimized independently - the fluorophore for high signal intensity and the quinone unit for specific enzymatic recognition - thereby achieving high signal-to-noise ratio while maintaining reasonable structural complexity
Solution Approach 2:
The probe is designed in a non-fluorescent precursor form (NQ-DCP) that requires activation by hNQO1 to generate the fluorescent signal. This preliminary action approach ensures that the fluorescent signal is generated only at the target site through enzymatic conversion, eliminating background noise from non-specific fluorescence and achieving high signal-to-noise ratio
2Ease of operation
If conventional probes are used, then the detection is specific to hNQO1, but cell permeability is limited
Solution Approach 1:
The physical and chemical parameters of the probe are optimized for cell permeability while maintaining hNQO1 specificity. The molecular weight, lipophilicity, and charge distribution of the probe are tuned to facilitate efficient cell membrane penetration. The quinone propionic acid moiety maintains high affinity for hNQO1 through specific molecular recognition, ensuring detection specificity is preserved despite enhanced permeability
3Illumination intensity
If existing fluorescent probes are used, then the Stokes shift is insufficient, but the probe design is straightforward
Solution Approach 1:
The probe utilizes a fluorophore (dicyanoisophorone) with optimized optical properties that exhibit a large Stokes shift between excitation and emission wavelengths. This color shift characteristic allows effective separation of excitation and emission light paths, reducing background interference and enhancing signal detection. The quinone propionic acid unit is conjugated to the fluorophore in a manner that preserves this optical property while enabling enzymatic activation
4Measurement precision
If probes with high fluorescence intensity are used, then the detection sensitivity is improved, but cytotoxicity increases
Solution Approach 1:
The fluorescent signal generation is extracted from the probe's bulk structure and localized to a specific fluorophore unit (dicyanoisophorone) that is released only after hNQO1-mediated cleavage of the quinone propionic acid linkage. This extraction ensures that high fluorescence intensity is generated selectively at the target site without the probe molecule itself being toxic to cells. The non-fluorescent precursor form enters cells without causing harm, and fluorescence is activated only upon specific enzymatic recognition
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
NQ-DCP enables sensitive and selective detection of hNQO1 activity in cancer cells, providing a high target-to-background ratio and facilitating accurate visualization of cancer cells, thereby improving cancer diagnosis and management.
Implementation Method 1
The hNQO1 reduces the probe releases a fluorescent DCP
Implementation Method 2
which underwent lactonization to release fluorescent probe
Data Source
AI summary
The present invention includes a probe, an assay, a method of detecting, a human NAD(P)H quinone oxidoreductase-1 (hNQO1) enzyme activity with a fluorescent probe comprising a quinone propionic acid (QPA) conjugated to dicyanoisophorone (DCP), wherein the hNQO1 reduces the probe to releases a fluorescent DCP, and a method of making the same.